2023 Winter;69(1):37-40
Jeff Emmick, vice president of product development at Lilly Diabetes, said Tirzepatide is the first investigational medicine to deliver more than 20% weight loss on average in a phase 3 study, reinforcing our confidence in its potential to help people living with obesity, obesity is a chronic disease that requires effective treatment options. Benefits of Tirzepatide for Weight Loss Based on clinical trials, patients using Tirzepatide may experience: Substantial A1C reductions Increased weight loss Improvements in cardiometabolic measures Improved triglycerides levels Reduced appetite Decreased blood pressure Improved insulin sensitivity Conclusion Tirzepatide had an overall safety and tolerability profile, similar to other therapies approved for the treatment of obesity
However, if semaglutide causes nausea early in treatment, this symptom may temporarily distract from pain management or reduce appetite for meals needed to stabilize blood sugar
Fat oxidation is driven by caloric deficit, not methyl donors
What, what, what am I, how am I different than the other human beings
Directions Hold an appropriate amount in your palm after washing your face, avoiding the area around your eyes and mouth, and massage the gel in a circular motion
